During the past decade, Central New York Clinical Research conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 14 clinical trials were completed, i.e. on average, 127.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 9 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Central New York Clinical Research" #1 sponsor was "Pfizer" with 11 trials, followed by "Allergan" with 3 trials sponsored, "Orexigen Therapeutics, Inc" with 2 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored and "Janssen Research & Development, LLC" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Central New York Clinical Research" #1 collaborator was "Procter and Gamble" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Central New York Clinical Research" are "Migraine" (6 trials), "Migraine, With or Without Aura" (4 trials), "Obesity" (4 trials), "Low Back Pain" (2 trials) and "Overweight" (2 trials). Many other conditions were trialed in "Central New York Clinical Research" in a lesser frequency.

Most popular intervention types in "Central New York Clinical Research" are "Drug" (19 trials), "Behavioral" (3 trials), "Biological" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Rimegepant" (4 trials), "Ancillary therapy" (2 trials), "Placebo-matching Ubrogepant" (2 trials) and "Ubrogepant" (2 trials). Other intervention names were less common.

The vast majority of trials in "Central New York Clinical Research" are 21 trials for "All" genders.

Currently, there are NaN active trials in "Central New York Clinical Research". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Central New York Clinical Research, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Central New York Clinical Research, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".